Buprenorphine and Naloxone (Buprenorphine and Naloxone) (Tablet) 2; .5 mg/1; mg/1

Buprenorphine and Naloxone tablet combines two medications to treat opioid dependence. This sublingual formulation helps reduce withdrawal symptoms and cravings. It is designed for use under medical supervision. Commonly prescribed for opioid use disorder management.

Strength

2; .5 mg/1; mg/1

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Buprenorphine and Naloxone is used to treat opioid dependence by reducing withdrawal symptoms and cravings. It works by binding to opioid receptors in the brain, which helps stabilize patients during recovery. This medication is part of a comprehensive treatment plan for opioid use disorder. It is not intended for pain relief or recreational use.

Side Effects

This combination medication may cause mild drowsiness, headache, or nausea when first starting treatment. Some users report constipation or sweating as common effects. These effects often lessen as the body adjusts to the medication. It is important to follow dosing instructions carefully.

Precautions & Warnings

Store this medication in a secure, childproof location away from moisture and heat. Keep it out of reach of others, especially children or pets. Do not share this medication with anyone, even if they have similar symptoms. Dispose of unused tablets properly through pharmacy take-back programs.

Avoid Interactions

Avoid alcohol and sedatives while taking Buprenorphine and Naloxone, as they can increase drowsiness or breathing problems. Certain medications, like benzodiazepines or other opioids, may interact unpredictably. Always inform your healthcare provider about all prescription and over-the-counter drugs you are taking.

Frequently Asked Questions

It is used to treat opioid dependence by reducing withdrawal symptoms and cravings as part of a recovery program.

Store in a secure, childproof place away from moisture and heat, and follow local disposal guidelines.

Avoid alcohol as it may increase drowsiness or breathing problems when combined with this medication.

Consult a healthcare provider to determine if this medication is appropriate for your specific situation.

Take the missed dose as soon as you remember, but skip it if it is almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.